Supplementary Appendix
|
|
- Pamela Underwood
- 5 years ago
- Views:
Transcription
1 Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Futier E, Constantin J-M, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013;369: DOI: /NEJMoa (PDF updated October 10, 2013.)
2 Table of contents Supplementary appendix List of IMPROVE trial investigators 3 Acknowledgments 3 Inclusion criteria 4 Exclusion criteria 5 Trial settings for intraoperative ventilation 5 Trial definitions for postoperative complications 6 Protocol violations 8 Handling of missing data 8 Figure S1. Time-to-event curve for non-invasive or invasive ventilation for postoperative acute respiratory failure within 30 days after surgery 9 Figure S2. Time-to-event curve for postoperative pneumonia within 30 days after surgery 10 Figure S3. Time-to-event curve for postoperative ALI/ARDS within 30 days after surgery 11 Figure S4. Time-to-event curve for postoperative sepsis, severe sepsis and septic shock within 30 days after surgery 12 Table S1. Univariate and multivariate analysis of factors associated with the primary outcome 13 Table S2. More details on intraoperative procedures 16 Table S3. Unadjusted and adjusted analyses for outcomes 18 Table S4. Unadjusted and adjusted analyses for outcomes excluding patients with the higher risk for postoperative pulmonary complications 21 Table S5. Postoperative gas Exchange 24 References 25 2
3 Intraoperative PROtective VEntilation (IMPROVE) trial investigators Steering Committee: Emmanuel Futier, Samir Jaber, Jean-Michel Constantin, Catherine Paugam-Burtz, Emmanuel Marret, Marc Beaussier, Jean-Yves Lefrant, Bernard Allaouchiche. Trial Management Committee: Emmanuel Futier, Jean-Michel Constantin Scientific Committee: Emmanuel Futier, Samir Jaber, Jean-Michel Constantin, Marc Leone Trial Monitoring and Research Coordinators: Dominique Morand, Sandrine Saugues, Julien Pascal, Fabrice Kwiatkowski Data Monitoring and Safety Committee: Elie Azoulaz, Karim Asehnoune, Lise Laclautre Perrier Statistical and data coordination: Bruno Pereira Writing Committee: Emmanuel Futier, Samir Jaber, Jean-Michel Constantin Participating sites and investigators: Estaing Hospital, Clermont-Ferrand, France: E Futier, JM Constantin, JE Bazin, A Petit, A Gérard, O Cherbis Saint Eloi Hospital, Montpellier, France: S Jaber, D Verzilli, A De Jong, M El Kamel Beaujon Hospital, AP-HP, Paris, France: C Paugam-Burtz, M Eurin, A Neuschwander Tenon Hospital, AP-HP, Paris, France: E Marret, ML Brulé, J de Montblanc, JF Perrier, O Szymkiewicz Saint Antoine Hospital, AP-HP, Paris, France: M Beaussier, C Gutton Edouard Herriot Hospital, Lyon, France: B Allaouchiche, C Le Goff, A Challan-Belval Caremeau Hospital, Nîmes, France: J Ripart, JY Lefrant Acknowledgments We wish to thank all patients who participated in the study, and the clinical and research staff at all trial sites, without whose assistance the IMPROVE study would never have been completed. We would especially like to thank Mervyn Singer for his valuable advice during the preparation of the manuscript. We also wish to thank the monitors of the trial, in particular Dominique Morand and Sandrine Saugues at the Direction de la Recherche Clinique (DRC), Clermont-Ferrand University Hospital for coordinating the monitoring of the trial. 3
4 Inclusion criteria 1. All adult patients older than 40 years (and < 90 years) 2. Scheduled for planned laparoscopic or non-laparoscopic major abdominal surgery 3. With an expected duration of 2 hours 4. With a preoperative risk index 1 for postoperative pulmonary complications of 2 5. And informed consent obtained 6. And valid affiliation to the Social Security System Preoperative risk index 1 Risk factor Point Value Type of surgery Abdominal aortic aneurysm repair 15 Upper abdominal 10 Age 80 years years years years 4 Functional status Totally dependent 10 Partially dependent 6 Weight loss > 10% in past 6 months 7 History of chronic obstructive pulmonary disease 5 General anesthesia 4 Impaired sensorium 4 History of cerebrovascular accident 4 Blood urea nitrogen level < 2.86 mmol/l (< 8 mg/dl) mmol/l (22 30 mg/dl) mmol/l ( 30 mg/dl) 3 Transfusion > 4 units 3 Emergency surgery 3 Steroid use for chronic condition 3 Current smoker within 1 year 3 Alcohol intake > 2 drinks/d in past 2 weeks 2 Risk Class Risk Class 1 Risk Class 2 Risk Class 3 Risk Class 4 Risk Class points points points points > 55 points 4
5 Exclusion criteria 1. Mechanical ventilation of >1 hour within the last 2 weeks before surgery 2. Body mass index 35 kg/m 2 3. Acute respiratory failure (pneumonia, acute lung injury or acute respiratory distress syndrome) 4. Emergency 5. Sepsis or septic shock 6. Progressive neuromuscular illness 7. Intra-thoracic surgery 8. Pregnancy 9. Refusal to participate Trial settings for intraoperative ventilation Patients were randomly assigned to receive either non-protective (non-protective ventilation group) or lung protective (lung-protective ventilation group) mechanical ventilation throughout the surgical procedure. Patients in the non-protective ventilation group had a tidal volume of 10 to 12 ml per kilogram predicted body weight, zero PEEP and no recruitment maneuver. Patients in the lung-protective ventilation group had a tidal volume of 6 to 8 ml per kilogram predicted body weight, a PEEP level of 6 to 8 cm of water and recruitment maneuvers. Recruitment maneuvers consisted of a continuous positive airway pressure of 30 cm of water for 30 sec, and were applied immediately after tracheal intubation and every 30 min thereafter until the end of surgery. Predicted body weight (PBW) was calculated according to a predefined formula with: x (centimeters of height 152.4) for males and x (centimeters of height 152.4) for females. In each group, patients were ventilated using the volume-controlled ventilation strategy using an anesthesia ventilator: 1. Avance (Datex-Ohmeda, General Electric, Helsinki, Finland) 2. Aisys (Datex-Ohmeda, General Electric, Helsinki, Finland) 3. Primus (Dräger, Lübbeck, Germany) In each group, attending anesthesiologists were advised to use an inspired oxygen fraction (F I O 2 ) below 0.5 and to maintain oxygen saturation 95%. The inspiratory to expiratory time ratio was set at 1:2, with a respiratory rate adjusted to maintain normocapnia (end-tidal carbon dioxide concentration of mmhg). Main Ventilator settings Lung-protective Ventilation group Non-protective Ventilation group Tidal volume, ml/kg PBW PEEP, cmh 2 O Recruitment maneuver After intubation and every 30 min No Recruitment maneuvers were standardized among centers and performed as follows: 1. Pressure Support Ventilation (PSV) mode 2. Positive End-expiratory Pressure (PEEP) set to 30 cm of water 3. Inspiratory gas flow set to the highest value 4. Duration of the maneuver = 30 sec 5
6 In case of desaturation (defined as a peripheral oxygen saturation of less than 92%), a rescue therapy was proposed and consisted of increasing F I O 2 to 100% in the both groups until oxygen saturation had reached the target value (oxygen saturation 95%), and applying PEEP and/or recruitment maneuver in the group assigned to non-protective ventilation. Trial definitions for postoperative complications Postoperative pulmonary complications were scored using a grade scale 2 ranging from 0 to 4, with grade 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively the worse forms of complications. Grade scale for postoperative pulmonary complications. 2 Grade 1 - Cough, dry - Microatelectasis: abnormal lung findings and temperature > 37.5 C without other documented cause; results of chest radiograph either normal - Dyspnea, not due to other documented cause Grade 2 - Cough, productive, not due to other documented cause - Bronchospasm: new wheezing or pre-existent wheezing resulting in change therapy - Hypoxemia - Atelectasis: radiological confirmation plus either temperature > 37.5 C or abnormal lung findings - Hypercarbia, transient, requiring treatment, such as naloxone or increased manual or mechanical ventilation Grade 3 - Pleural effusion, resulting in thoracentesis - Pneumonia, suspected: radiological evidence without bacteriological confirmation - Pneumonia, proved: radiological evidence and documentation of pathological organism by Gram stain or culture - Pneumothorax - Re-intubation postoperative or intubation, period of ventilator dependence (non-invasive or invasive ventilation) 48 hours Grade 4 Ventilatory failure: postoperative non-invasive ventilation dependence 48 hours, or re-intubation with subsequent period of ventilator dependence 48 hours Postoperative hypoxemia was defined as a PaO 2 < 60 mmhg or SpO 2 < 90% on room air. Pneumonia was suspected upon the presence of new and/or progressive pulmonary infiltrates on chest radiograph plus two or more of the following criteria: - Fever 38.5 C or hypothermia <36 C - Leukocytosis 10 WBC/mm 3 or leukopenia < 4000 WBC/mm 3 - Purulent sputum and/or new onset or worsening cough or dyspnea Atelectasis was defined as lung opacification with shift of the mediastinum, hilum or hemidiaphragm towards the affected area and compensatory overinflation in the adjacent nonatelectatic lung. 6
7 The SIRS criteria were (we used the most deranged value recorded after surgery): 1. Core temperature > 38 C or <36 C. (Core temperature was rectal or tympanic). If oral, inguinal or axillary temperatures were used, 0.5 C were added to the measured value. 2. Heart rate > 90 beats per minute. If patient had an atrial arrhythmia, record the ventricular rate. If patients have a known medical condition or are receiving treatment that would prevent tachycardia (for example, heart block or beta blockers), they must meet two of the remaining three SIRS criteria. 3. Respiratory rate > 20 breaths per minute or a PaCO 2 < 32 mmhg (4.3 kpa) or mechanical ventilation for an acute process. 4. White Blood Cell (WBC) count of >12 x 10 9 /l or < 4 x 10 9 /l. Sepsis was defined as a 1. Defined focus of infection and 2. At least two systemic inflammatory response syndrome (SIRS) criteria. Defined focus of infection was indicated by either an organism grown in blood or sterile site, or an abscess or infected tissue (e.g. pneumonia, peritonitis, urinary tract, vascular line infection, soft tissue, etc.). Severe sepsis was defined by sepsis plus at least one organ failure, hypotension or hypoperfusion. Septic shock was sepsis-induced hypotension despite adequate fluid resuscitation along with the presence of perfusion abnormalities. 7
8 Protocol violations Four hundred patients were included in the modified intention-to-treat analysis and were followed up to 30 days after surgery. One patient in the traditional ventilation group received the lung-protective ventilation strategy, and was analyzed in the group to which he was assigned. Handling of missing data Missing baseline variables (Table 1): No missing values. We had full data sets on all 400 patients. Missing intraoperative procedures (Table 2): No missing values. We had full data sets on all 400 patients. Missing outcome data: For the primary outcome measure and most of the secondary outcomes, we had full data sets on all 400 patients. There were missing data for following secondary outcomes measures (Table 4): - ph - PaO 2 - PaCO 2 - HCO SaO 2 Multiple imputation method was performed using command mi from software STATA. mi impute assumes that missing data are missing at random; that is, missing values do not carry any extra information about why they are missing than what is already available in the observed data. mi replaces missing values with multiple sets of simulated values to complete the data, applies standard analyses to each completed dataset, and adjusts the obtained parameter estimates for missing-data uncertainty. The objective of mi is not to predict missing values as close as possible to the true ones but to handle missing data in a way resulting in valid statistical inference. Pattern has been considered with parameters used on multivariate analysis: randomization group, stratification variables (center, use of epidural analgesia), sex, preoperative risk index for postoperative pulmonary complications, duration of surgery (ranging from 2-4 hours, 4-6 hours or 6 hours) and blood transfusion. The number of patients where the measurements were documented in source data is presented. Mean (±SD) values and p-values are given for data obtained after missing-data imputation (N = in each randomization group). Analyses on complete data were also carried out and confirm results presented. 8
9 Figure S1. Kaplan-Meier curve estimates of the probability for requiring intubation or non-invasive ventilation for postoperative acute respiratory failure within 30 days after surgery between the lung non-protective ventilation group and the lung protective ventilation group. (P<0.001, log-rank test). Probability of event Non-protective ventilation Protective ventilation No. at risk Days since surgery Non-protective ventilation Lung protective ventilation
10 Figure S2. Kaplan-Meier curve estimates of the probability for postoperative pneumonia within 30 days after surgery between the lung nonprotective ventilation group and the lung protective ventilation group. (P<0.001, log-rank test). Probability of event Non-protective ventilation Protective ventilation No. at risk Days since surgery Non-protective ventilation Lung protective ventilation
11 Figure S3. Kaplan-Meier curve estimates of the probability for postoperative ALI/ARDS within 30 days after surgery between the lung non-protective ventilation group and the lung protective ventilation group. (P=0.018, log-rank test). Probability of event Non-protective ventilation Protective ventilation No. at risk Days since surgery Non-protective ventilation Lung protective ventilation
12 Figure S4. Kaplan-Meier curve estimates of the probability for postoperative sepsis, severe sepsis and septic shock within 30 days after surgery between the non-protective ventilation group and the lung protective ventilation group. (P=0.003, log-rank test). Probability of event Non-protective ventilation Protective ventilation No. at risk Days since surgery Non-protective ventilation Lung protective ventilation
13 Table S1. Univariate and multivariate analysis of factors associated with the primary outcome. Characteristic Yes (N = 76) Primary outcome Univariate Analysis No (N = 324) Odds ratio (95%CI) P Value Odds ratio* (95%CI) Multivariate Analysis P Value Odds ratio** (95%CI) Randomization group Lung protective ventilation 21 (10.5) 179 (89.5) 0.31 ( ) < ( ) < ( ) < Traditional mechanical ventilation 55 (27.5) 145 (72.5) 1.00 Patient-specific risk factors Age (year) no. (%) (8.7) 42 (91.3) (13.0) 94 (87.0) 1.56 ( ) 1.39 ( ) (20.6) 104 (79.4) 2.73 ( ) 1.96 ( ) (26.3) 73 (73.7) 3.74 ( ) 3.72 ( ) (29.4) 12 (70.6) 4.37 ( ) 5.32 ( ) 0.05 Gender no. (%) Male 59 (24.9) 178 (75.1) 2.85 ( ) < ( ) ( ) Female 17 (10.4) 146 (89.6) 1.00 Body mass index kg/m ± ± ( ) 0.26 Predicted body weight kg 66.0± ± ( ) 0.02 Preoperative Risk index no. (%) < Risk class 2 24 (11.9) 177 (88.1) Risk class 3 46 (24.6) 141 (75.4) 2.41 ( ) 1.73 ( ) 0.07 Risk class 4 6 (50) 6 (50) 7.37 ( ) 7.42 ( ) Smoker no. (%) Yes 27 (26.7) 74 (73.3) 1.86 ( ) ( ) No 49 (16.4) 250 (83.6) 1.00 Alcohol intake Yes 9 (29.0) 22 (71.0) 1.84 ( ) 0.14 P Value
14 No 67 (18.2) 302 (80.8) 1.00 Functional dependence Yes 8 (50.0) 8 (50.0) 4.65 ( ) ( ) 0.03 No 68 (17.7) 316 (82.3) 1.00 COPD Yes 11 (27.5) 29 (72.5) 1.72 ( ) 0.15 No 65 (18.1) 295 (81.9) 1.00 Weight loss > 10% Yes 24 (28.6) 60 (71.4) 2.03 ( ) 0.01 No 52 (16.5) 264 (83.5) 1.00 Chronic use of steroid Yes 1 (9.1) 10 (90.9) 0.42 ( ) 0.70 No 75 (19.3) 314 (80.7) 1.00 Laparoscopic surgery no. (%) Yes 10 (13.2) 75 (23.1) 0.50 ( ) 0.06 No 66 (86.8) 249 (76.9) 1.00 Cancer diagnosis no. (%) Yes 70 (21.9) 249 (78.1) 3.56 ( ) No 6 (7.4) 75 (92.6) 1.00 Factors related to intraoperative patient management Epidural analgesia no. (%) Yes 31 (19.4) 129 (80.6) 1.04 ( ) 0.88 No 45 (18.7) 195 (81.3) Duration of surgical procedure 2-4 hours 19 (12.6) 132 (87.4) 1.00 < hours 27 (17.9) 124 (82.1) 1.51 ( ) 1.21 ( ) ( ) 0.67 >6 hours 28 (32.9) 57 (67.1) 3.41 ( ) 3.02 ( ) ( ) Blood transfusion no. (%) Yes 26 (36.6) 45 (63.4) 3.37 ( ) < ( ) ( ) 0.03 No 47 (14.6) 274 (85.4) 1.00 Blood transfusion Number of unit 1.1± ± ( ) < 0.001
15 Blood losses (ml) median (interquartile range) 500 ( ) 250 ( ) 1.00 ( ) < Volume of fluids (ml) median (interquartile range) Crystalloid 3000 ( ) 0 ( ) 1.00 ( ) < Colloid 1000 ( ) 500 ( ) 1.00 ( ) Need for vasopressor no. (%) Yes 23 (29.9) 54 (70.1) 2.19 ( ) No 52 (16.3) 268 (83.7) 1.00 Plus-minus values are means±sd. COPD denotes chronic obstructive pulmonary disease and PPC postoperative pulmonary complications. Two models were considered for the logistic regression analysis: first considering each patient-specific risk factor for predicting postoperative pulmonary complications in the preoperative risk index (*), and second, using the multifactorial risk index (**). 1 The criterion for entering variables tested in the model were selected if P<0.10 and according to clinical significant parameters. 2 Preoperative risk index of postoperative pulmonary complications. 1 The risk index ranges from class 1 to class 5, with higher risk class indicating higher risk of complications. Patients having a risk class of 2 or more were eligible for participation. Ten patients had both laparoscopic and non-laparoscopic procedures (intraoperative conversion from laparoscopic to open surgery)
16 Table S2. More details on intraoperative procedures. Variable Non-protective Ventilation group (N = ) Lung Protective Ventilation group (N = ) P Value Tidal volume ml 719.0± ±75.6 <0.001 Tidal volume ml per kilogram PBW* 11.1± ±0.8 <0.001 PEEP cmh 2 O median (interquartile range) At baseline 0 (0 0) 6 (6 8) <0.001 End of surgery 0 (0 0) 6 (6 8) <0.001 Recruitment maneuver median (interquartile range) 0 (0 0) 9 (6 12) <0.001 Peak pressure cmh 2 O At baseline 20.1± ± End of surgery 20.6± ± Plateau pressure cmh 2 O At baseline 16.1± ± End of surgery 16.6± ±2.6 <0.001 Respiratory system compliance ml/cmh 2 O At baseline 48.4± ± End of surgery 45.1± ±26.7 <0.001 F I O 2 % 47.2± ± Volume of fluids median (interquartile range) Crystalloid L 2.0 ( ) 1.5 ( ) 0.47 Colloid L 0.5 ( ) 0.5 ( ) 0.97 Duration of surgery no. (%) hours 76 (39.6) 75 (38.5) 4-6 hours 75 (39.1) 76 (38.9) >6 hours 41 (21.3) 44 (22.6) Duration of mechanical ventilation min 344± ± Time to extubation min 31 (20 60) 30 (20 60) 0.61 Anesthetic drug no. (%) 0.45 Desflurane inhalation 157 (78.5) 163 (81.5) Sevoflurane inhalation 43 (21.5) 37 (18.5) Neuromuscular blocking agent no. (%) 0.45 Atracurium 81 (40.9) 74 (37.2) Cis-atracurium 117 (59.1) 125 (62.8) Intravenous opioid no. (%) 0.19 Sufentanil 160 (80.0) 170 (85) Remifentanil 40 (20.0) 30 (15) Blood loss ml median (interquartile range) 300 ( ) 300 ( ) 0.29 Blood transfusion no. (%) 37 (18.5) 34 (17.0) 0.79 Need for vasopressor no. (%) 42 (21.1) 35 (17.7) 0.45 Epidural analgesia no. (%) 77 (38.5) 83 (41.5)
17 Values are displayed as mean±sd unless otherwise stated. F I O 2 denotes inspired oxygen fraction, PBW predicted body weight, PEEP positive end-expiratory pressure. Detailed on intraoperative procedures are given in Table S2 in the Supplementary Appendix. * Predicted body weight was calculated as x [height (centimeters) 152.4] for males and x [height (centimeters) 152.4] for females. Duration of surgery is the time between skin incision and closure of the incision. Time to extubation is the time between the end of surgery and successful extubation. Criteria for extubation after surgery were: recovery of a spontaneous ventilation with an expired tidal volume between 5-8 ml/kg, respiratory rate between breaths/min, absence of residual neuromuscular blockade (assessed by a T4/T1 ratio 90%), peripheral oxygen saturation 95%, stable hemodynamics and a body temperature 36 C 17
18 Table S3. Unadjusted and adjusted analyses for outcomes. Variable Outcome Non-protective Ventilation group (N = ) Lung Protective Ventilation group (N = ) Unadjusted Relative Risk (95% CI) P Value* Adjusted Relative Risk (95% CI) P Value Primary outcome to Day 7 no. (%) 55 (27.5) 21 (10.5) 0.38 ( ) < ( ) Composite outcome to Day 30 no. (%) 58 (29.0) 25 (12.5) 0.43 ( ) < ( ) <0.001 Secondary outcome measures Pulmonary complications to Day 7 no. (%) Grade (15.0) 25 (12.5) 0.69 ( ) ( ) 0.16 Grade 3 42 (21.0) 10 (5.0) 0.24 ( ) < ( ) <0.001 Atelectasis to Day 7 no. (%) 34 (17.0) 13 (6.5) 0.38 ( ) ( ) Pneumonia to Day 7 no. (%) 16 (8.0) 3 (1.5) 0.19 ( ) ( ) ALI or ARDS to Day 7 no. (%) 6 (3.0) 1 (0.5) 0.17 ( ) ( ) 0.14 Need for invasive ventilation to Day 7 no. (%) 7 (3.5) 2 (1.0) 0.29 ( ) ( ) 0.26 Need for non-invasive ventilation to Day 7 no. (%) 29 (14.5) 9 (4.5) 0.31 ( ) ( ) Pulmonary complications to Day 30 no. (%) Grade (15.0) 25 (12.5) 0.70 ( ) ( ) 0.17 Grade 3 42 (21.0) 12 (6.0) 0.29 ( ) < ( ) <0.001 Pneumonia to Day 30 no. (%) 18 (9.0) 3 (1.5) 0.17 ( ) ( ) ALI or ARDS to Day 30 no. (%) 8 (4.0) 1 (0.5) 0.12 ( ) ( ) 0.07 Need for invasive ventilation to Day 30 no. (%) 13 (6.5) 3 (1.5) 0.23 ( ) ( ) Need for non-invasive ventilation to Day 30 no. (%) 29 (14.5) 11 (5.5) 0.38 ( ) ( ) Extra-pulmonary complications to Day 7 no. (%) SIRS 100 (50.0) 86 (43.0) 0.86 ( ) ( ) 0.37 Sepsis 29 (14.5) 13 (6.5) 0.45 ( ) ( )
19 Severe sepsis or septic shock 9 (4.5) 8 (4.0) 0.89 ( ) ( ) 0.47 Extra-pulmonary complications to Day 30 no. (%) SIRS 103 (51.5) 86 (43.0) 0.83 ( ) ( ) 0.26 Sepsis 36 (18.0) 16 (8.0) 0.44 ( ) ( ) Severe sepsis or septic shock 11 (5.5) 8 (4.0) 0.73 ( ) ( ) 0.83 Surgical complications to Day 30 no. (%) Surgical site infection 15 (7.5) 9 (4.5) 0.60 ( ) ( ) 0.11 Intra-abdominal abscess 15 (7.5) 11 (5.5) 0.73 ( ) ( ) 0.49 Anastomotic leakage 44 (22.0) 24 (12.0) 0.54 ( ) ( ) Need for reoperation 20 (10) 15 (7.5) 0.75 ( ) ( ) Day mortality no. (%) 7 (3.5) 6 (3.0) 0.86 ( ) ( ) 0.83 Service utilization Mean Difference (95% CI) Mean Difference (95% CI) Days in hospital median (interquartile range) 13 (8 20) 11 (8 15) (-4.04 to -0.47) (-4.17 to -0.72) Days in ICU median (interquartile range) 7 (4 9) 6 (4 8) (-6.87 to 3.91) (-4.98 to 7.40) 0.69 Treatment-related adverse events Intraoperative hypotension no./total no. of recruitment procedures (%) Unadjusted Relative Risk (95% CI) Adjusted Relative Risk (95% CI) 0/8 (0.0) 29/1729 (1.7) NA NA NA NA Pneumothorax no. (%) 2 (1.0) 4 (2.0) 2.00 ( ) ( ) 0.18 Adjustment was performed for stratification variables (epidural analgesia and study center) and preoperative risk index for postoperative pulmonary complications, sex gender, duration of surgery and blood transfusion. * The Hochberg procedure was used to adjust for multiple testing of components of the composite primary outcome. The primary outcome measure was a composite of major pulmonary (defined as pneumonia or need for invasive or non-invasive ventilation for acute respiratory failure) and extra-pulmonary (defined as sepsis, septic shock or death) complications to Postoperative day 7. ALI denotes acute lung injury, CI 19
20 confidence intervals, ARDS acute respiratory distress syndrome, ICU intensive care unit, NA not applicable, SIRS systemic inflammatory response syndrome. All postoperative complications are defined according to consensus criteria (for details, see Supplementary Appendix). Postoperative pulmonary complications are scored using a grade scale 2, with 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively worse forms of pulmonary complications (for details, see Supplementary Appendix). Tracheal intubations for reoperation due to surgical complications were not used did not qualify as a postoperative pulmonary complication. 20
21 Table S4. Unadjusted and adjusted analyses for outcomes excluding patients with the higher risk (preoperative risk index of class 4 or more) for postoperative pulmonary complications (N=6 in each group) Variable Outcome Non-protective Ventilation group (N = 194) Lung Protective Ventilation group (N = 194) Unadjusted Relative Risk (95% CI) P Value* Adjusted Relative Risk (95% CI) Primary outcome to Day 7 no. (%) 51 (26.3) 19 (9.8) 0.37 ( ) < ( ) Composite outcome at Day 30 no. (%) 54 (27.8) 23 (11.9) 0.43 ( ) < ( ) Secondary outcome measures Pulmonary complications to Day 7 no. (%) Grade (15.4) 23 (11.8) 0.65 ( ) ( ) 0.11 Grade 3 39 (20.1) 10 (5.2) 0.26 ( ) < ( ) <0.001 Atelectasis to Day 7 no. (%) 32 (16.5) 13 (6.7) 0.41 ( ) ( ) Pneumonia to Day 7 no. (%) 16 (8.3) 3 (1.6) 0.19 ( ) ( ) ALI or ARDS to Day 7 no. (%) 6 (3.1) 1 (0.5) 0.17 ( ) ( ) 0.14 Need for invasive ventilation to Day 7 no. (%) 7 (3.6) 2 (1.0) 0.29 ( ) ( ) 0.26 Need for non-invasive ventilation to Day 7 no. (%) 27 (13.9) 9 (4.6) 0.33 ( ) ( ) Pulmonary complications to Day 30 no. (%) Grade (19.4) 23 (12.6) 0.65 ( ) ( ) 0.12 Grade 3 39 (20.1) 12 (6.2) 0.31 ( ) < ( ) <0.001 Pneumonia to Day 30 no. (%) 18 (9.3) 3 (1.6) 0.17 ( ) ( ) ALI or ARDS to Day 30 no. (%) 8 (4.1) 1 (0.5) 0.13 ( ) ( ) 0.07 Need for invasive ventilation to Day 30 no. (%) 12 (6.2) 3 (1.6) 0.25 ( ) ( ) Need for non-invasive ventilation to Day 30 no. (%) 27 (13.9) 11 (5.7) 0.41 ( ) ( ) 0.01 Extra-pulmonary complications to Day 7 no. (%) P Value 21
22 SIRS 97 (50.0) 83 (42.8) 0.86 ( ) ( ) 0.33 Sepsis 28 (14.4) 12 (6.2) 0.43 ( ) ( ) 0.03 Severe sepsis or septic shock 7 (3.6) 8 (4.1) 1.14 ( ) ( ) 0.35 Extra-pulmonary complications to Day 30 no. (%) SIRS 100 (51.6) 83 (42.8) 0.83 ( ) ( ) 0.23 Sepsis 35 (18.0) 15 (7.7) 0.43 ( ) ( ) Severe sepsis or septic shock 9 (4.6) 8 (4.1) 0.89 ( ) ( ) 0.70 Surgical complications to Day 30 no. (%) Surgical site infection 15 (7.7) 9 (4.6) 0.60 ( ) ( ) 0.11 Intra-abdominal abscess 15 (7.7) 10 (5.2) 0.67 ( ) ( ) 0.36 Anastomotic leakage 44 (22.7) 24 (12.4) 0.54 ( ) ( ) Need for reoperation 19 (9.8) 14 (7.2) 0.74 ( ) ( ) Day mortality no. (%) 6 (3.1) 5 (2.6) 0.83 ( ) ( ) 0.99 Service utilization Mean Difference (95% CI) Mean Difference (95% CI) Days in hospital median (interquartile range) 13 (8 20) 11 (8 15) (-4.17 to -0.50) (-4.41 to -0.89) Days in ICU median (interquartile range) 7 (4 9) 6 (4 8) (-7.12 to 4.05) (-4.98 to 7.40) 0.69 Treatment-related adverse events Intraoperative hypotension no./total no. of recruitment procedure (%) Unadjusted Relative Risk (95% CI) Adjusted Relative Risk (95% CI) 0/8 (0.0) 29/1693 (1.7) NA NA NA NA Pneumothorax no. (%) 2 (1.1) 4 (2.1) 2.00 ( ) ( ) 0.18 Adjustment was performed for stratification variables (epidural analgesia and study center) and preoperative risk index for postoperative pulmonary complications, sex gender, duration of surgery and blood transfusion. * The Hochberg procedure was used to adjust for multiple testing of components of the composite primary outcome. 22
23 The primary outcome measure was a composite of major pulmonary (defined as pneumonia or need for invasive or non-invasive ventilation for acute respiratory failure) and extra-pulmonary (defined as sepsis, septic shock or death) complications to Postoperative day 7. ALI denotes acute lung injury, CI confidence intervals, ARDS acute respiratory distress syndrome, ICU intensive care unit, NA not applicable, SIRS systemic inflammatory response syndrome. All postoperative complications are defined according to consensus criteria (for details, see Supplementary Appendix). Postoperative pulmonary complications are scored using a grade scale 2, with 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively worse forms of pulmonary complications. Tracheal intubation for reoperation due to surgical complications was not recorded as a pulmonary complication. 23
24 Table S5. Gas Exchange after Extubation and at Postoperative Day 1. Variable ph Non-protective Ventilation group (N = ) No. Assessed Value Lung Protective Ventilation group (N = ) P Value No. Assessed Value After extubation (0.05) (0.05) 0.02 Day (0.05) (0.05) 0.92 PaO 2 mmhg After extubation (46.6) (53.5) 0.66 Day (27.2) (28.5) 0.17 PaCO 2 mmhg After extubation (5.3) (4.6) 0.03 Day (5.0) (4.8) 0.17 HCO - 3 mmol/liter After extubation (2.6) (2.9) 0.35 Day (2.7) (2.5) 0.90 SaO 2 % After extubation (3.4) (3.2) 0.96 Day (3.3) (2.8) 0.04 Values are displayed as mean±sd. PaO 2 denotes arterial partial pressure of oxygen, PaCO 2 arterial partial pressure of carbon dioxide, SaO 2 arterial saturation of oxygen. Number of patients where the measurements were documented in source data. All gas exchange were measured on room air (F I O 2 = 0.21) after tracheal extubation. Gas exchange were measured on room air (F I O 2 = 0.21) unless peripheral oxygen saturation was below 95%. At Postoperative Day 1, 270 patients received oxygen: 142 (71%) patients and 128 (64%) patients in the traditional ventilation group and in the lung-protective ventilation group, respectively (P=0.14). Median oxygen concentration was 2.25 l/min (interquartile range, 1.5 to 3.0) in the traditional ventilation group and 2.0 l/min (interquartile range, 1.5 to 3.0) in the lung-protective ventilation group (P=0.11). 24
25 References 1. Arozullah AM, Khuri SF, Henderson WG, Daley J. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 1;135: Hulzebos EH, Helders PJ, Favie NJ, et al. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 6;296: Malek MH, Berger DE, Coburn JW. On the inappropriateness of stepwise regression analysis for model building and testing. Eur J Appl Physiol 7;101:
PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1).
PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1). 1 Inform Consent Date: / / dd / Mmm / yyyy 2 Patient identifier: Please enter the 6 digit Patient identification number from your site patient log
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationSupplementary Online Content
1 Supplementary Online Content Leme AC, Hajjar LA, Volpe MS, et al. Effect of intensive vs moderate alveolar recruitment strategies added to lung-protective ventilation on postoperative pulmonary complications:
More informationPostoperative Respiratory failure( PRF) Dr.Ahmad farooq
Postoperative Respiratory failure( PRF) Dr.Ahmad farooq Is it really or/only a postoperative issue Multi hit theory first hits second hits Definition Pulmonary gas exchange impairment that presents after
More informationLAS VEGAS Case Report Form 1 Intra-Operative
LAS VEGAS Case Report Form 1 Intra-Operative Patient Informed Consent 1. Informed consent applicable: yes no (choose no if waived by local EC) 1.1 If applicable; was consent obtained? yes no 1.2 If yes,
More informationA Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article A Trial of Intraoperative Low-Tidal-Volume in Abdominal Surgery Emmanuel Futier, M.D., Jean-Michel Constantin, M.D., Ph.D., Catherine
More informationSupplementary Online Content
Supplementary Online Content Fernandez-Bustamante A, Frendl G, Sprung J, et al. Multicenter assessment of postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic
More informationSupplementary Online Content 2
Supplementary Online Content 2 van Meenen DMP, van der Hoeven SM, Binnekade JM, et al. Effect of on demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive
More informationLandmark articles on ventilation
Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP
More informationIndex. Note: Page numbers of article titles are in boldface type
Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: The National Heart, Lung, and Blood Institute Acute Respiratory
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
More informationSurviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality
More informationRespiratory insufficiency in bariatric patients
Respiratory insufficiency in bariatric patients Special considerations or just more of the same? Weaning and rehabilation conference 6th November 2015 Definition of obesity Underweight BMI< 18 Normal weight
More informationAcute Respiratory Distress Syndrome (ARDS) An Update
Acute Respiratory Distress Syndrome (ARDS) An Update Prof. A.S.M. Areef Ahsan FCPS(Medicine) MD(Critical Care Medicine) MD ( Chest) Head, Dept. of Critical Care Medicine BIRDEM General Hospital INTRODUCTION
More informationSECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION
SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION DEMOGRAPHIC INFORMATION Given name Family name Date of birth Consent date Gender Female Male Date of surgery INCLUSION & EXCLUSION CRITERIA YES
More informationCardiorespiratory Physiotherapy Tutoring Services 2017
VENTILATOR HYPERINFLATION ***This document is intended to be used as an information resource only it is not intended to be used as a policy document/practice guideline. Before incorporating the use of
More informationQuickLung Breather Patient Settings
The QuickLung Breather is capable of simulating a spontaneously breathing patient in a variety of modes and patterns. In response to customer requests, we have compiled five common respiratory cases below.
More informationSupplementary Online Content
Supplementary Online Content Jaber S, Lescot T, Futier E, et al; NIVAS Study Group. Effect of noninvasive ventilation on tracheal reintubation among patients with hypoxemic respiratory failure following
More informationFariba Rezaeetalab Associate Professor,Pulmonologist
Fariba Rezaeetalab Associate Professor,Pulmonologist rezaitalabf@mums.ac.ir Patient related risk factors Procedure related risk factors Preoperative risk assessment Risk reduction strategies Age Obesity
More informationARDS Assisted ventilation and prone position. ICU Fellowship Training Radboudumc
ARDS Assisted ventilation and prone position ICU Fellowship Training Radboudumc Fig. 1 Physiological mechanisms controlling respiratory drive and clinical consequences of inappropriate respiratory drive
More informationProne ventilation revisited in H1N1 patients
International Journal of Advanced Multidisciplinary Research ISSN: 2393-8870 www.ijarm.com DOI: 10.22192/ijamr Volume 5, Issue 10-2018 Case Report DOI: http://dx.doi.org/10.22192/ijamr.2018.05.10.005 Prone
More informationAPRV Ventilation Mode
APRV Ventilation Mode Airway Pressure Release Ventilation A Type of CPAP Continuous Positive Airway Pressure (CPAP) with an intermittent release phase. Patient cycles between two levels of CPAP higher
More informationImpact of Tidal Volume on Complications after Thoracic Surgery
Management of One-lung Ventilation Impact of Tidal Volume on Complications after Thoracic Surgery ABSTRACT Background: The use of lung-protective ventilation (LPV) strategies may minimize iatrogenic lung
More informationOxygenation Failure. Increase FiO2. Titrate end-expiratory pressure. Adjust duty cycle to increase MAP. Patient Positioning. Inhaled Vasodilators
Oxygenation Failure Increase FiO2 Titrate end-expiratory pressure Adjust duty cycle to increase MAP Patient Positioning Inhaled Vasodilators Extracorporeal Circulation ARDS Radiology Increasing Intensity
More informationLecture Notes. Chapter 9: Smoke Inhalation Injury and Burns
Lecture Notes Chapter 9: Smoke Inhalation Injury and Burns Objectives List the factors that influence mortality rate Describe the nature of smoke inhalation and the fire environment Recognize the pulmonary
More informationIntroduction and Overview of Acute Respiratory Failure
Introduction and Overview of Acute Respiratory Failure Definition: Acute Respiratory Failure Failure to oxygenate Inadequate PaO 2 to saturate hemoglobin PaO 2 of 60 mm Hg ~ SaO 2 of 90% PaO 2 of 50 mm
More informationFacilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Care Unit (FELLOW)
Facilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Data Analysis Plan: Apneic Oxygenation vs. No Apneic Oxygenation Background Critically ill patients
More informationHandling Common Problems & Pitfalls During. Oxygen desaturation in patients receiving mechanical ventilation ACUTE SEVERE RESPIRATORY FAILURE
Handling Common Problems & Pitfalls During ACUTE SEVERE RESPIRATORY FAILURE Pravit Jetanachai, MD QSNICH Oxygen desaturation in patients receiving mechanical ventilation Causes of oxygen desaturation 1.
More informationTRIALS. Emmanuel Futier 1,2*, Catherine Paugam-Burtz 3, Jean-Michel Constantin 1, Bruno Pereira 4 and Samir Jaber 2
Futier et al. Trials 2013, 14:341 TRIALS STUDY PROTOCOL Open Access The OPERA trial - comparison of early nasal high flow oxygen therapy with standard care for prevention of postoperative hypoxemia after
More informationISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis
Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions
More informationHow to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion
How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion Disclosure Slide No COI and no disclosures. Hospital Mortality rate : is it
More informationWeaning from Mechanical Ventilation. Dr Azmin Huda Abdul Rahim
Weaning from Mechanical Ventilation Dr Azmin Huda Abdul Rahim Content Definition Classification Weaning criteria Weaning methods Criteria for extubation Introduction Weaning comprises 40% of the duration
More informationFrederic J., Gerges MD. Ghassan E. Kanazi MD., Sama, I. Jabbour-Khoury MD. Review article from Journal of clinical anesthesia 2006.
Frederic J., Gerges MD. Ghassan E. Kanazi MD., Sama, I. Jabbour-Khoury MD. Review article from Journal of clinical anesthesia 2006 Introduction Laparoscopic surgery started in the mid 1950s. In recent
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients
More informationFAILURE OF NONINVASIVE VENTILATION FOR DE NOVO ACUTE HYPOXEMIC RESPIRATORY FAILURE: ROLE OF TIDAL VOLUME
FAILURE OF NONINVASIVE VENTILATION FOR DE NOVO ACUTE HYPOXEMIC RESPIRATORY FAILURE: ROLE OF TIDAL VOLUME Guillaume CARTEAUX, Teresa MILLÁN-GUILARTE, Nicolas DE PROST, Keyvan RAZAZI, Shariq ABID, Arnaud
More informationDoes proning patients with refractory hypoxaemia improve mortality?
Does proning patients with refractory hypoxaemia improve mortality? Clinical problem and domain I selected this case because although this was the second patient we had proned in our unit within a week,
More information1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.
Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F
More informationWeaning and extubation in PICU An evidence-based approach
Weaning and extubation in PICU An evidence-based approach Suchada Sritippayawan, MD. Div. Pulmonology & Crit Care Dept. Pediatrics Faculty of Medicine Chulalongkorn University Kanokporn Udomittipong, MD.
More informationThe use of proning in the management of Acute Respiratory Distress Syndrome
Case 3 The use of proning in the management of Acute Respiratory Distress Syndrome Clinical Problem This expanded case summary has been chosen to explore the rationale and evidence behind the use of proning
More informationNON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018
NON-INVASIVE VENTILATION Lijun Ding 23 Jan 2018 Learning objectives What is NIV The difference between CPAP and BiPAP The indication of the use of NIV Complication of NIV application Patient monitoring
More informationExclusion Criteria 1. Operator or supervisor feels specific intra- procedural laryngoscopy device will be required.
FELLOW Study Data Analysis Plan Direct Laryngoscopy vs Video Laryngoscopy Background Respiratory failure requiring endotracheal intubation occurs in as many as 40% of critically ill patients. Procedural
More informationApplication of Lung Protective Ventilation MUST Begin Immediately After Intubation
Conflict of Interest Disclosure Robert M Kacmarek Managing Severe Hypoxemia!" 9-28-17 FOCUS Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts I disclose
More informationFluid restriction is superior in acute lung injury and ARDS
TAKE-HOME POINTS FROM LECTURES BY CLEVELAND CLINIC AND VISITING FACULTY MEDICAL GRAND ROUNDS CME CREDIT HERBERT P. WIEDEMANN, MD Chairman, Department of Pulmonary, Allergy, and Critical Care Medicine,
More informationDURING one-lung ventilation (OLV), inflammation
Effect of Therapeutic Hypercapnia on Inflammatory Responses to One-lung Ventilation in Lobectomy Patients Wei Gao, M.D., Dong-Dong Liu, M.D., Di Li, M.D., Guang-xiao Cui, M.D., Ph.D. ABSTRACT Background:
More informationACUTE RESPIRATORY DISTRESS SYNDROME
ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe
More informationARDS Management Protocol
ARDS Management Protocol February 2018 ARDS Criteria Onset Within 1 week of a known clinical insult or new or worsening respiratory symptoms Bilateral opacities not fully explained by effusions, lobar/lung
More informationNIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity
NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Use of NIV 1998-2010 50 45 40 35 30 25 20 15 10 5 0 1998
More informationComposite of pneumonia, re-intubation, or death within 30 days of randomisation.
Appendix: definitions Clinical outcome measures Primary outcome measure Composite of pneumonia, re-intubation, or death within 30 days of randomisation. Pneumonia Care will be taken to distinguish between
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationInformation Often Given to the Nurse at the Time of Admission to the Postanesthesia Care Unit
Information Often Given to the Nurse at the Time of Admission to the Postanesthesia Care Unit * Patient s name and age * Surgical procedure and type of anesthetic including drugs used * Other intraoperative
More informationWhat is the next best step?
Noninvasive Ventilation William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center What is the next best step? 65 year old female
More informationOSCAR & OSCILLATE. & the Future of High Frequency Oscillatory Ventilation (HFOV)
& & the Future of High Frequency Oscillatory Ventilation (HFOV) www.philippelefevre.com What do we know already? Sud S et al. BMJ 2010 & Multi-centre randomised controlled trials of HFOV verses current
More informationSupplementary Online Content
Supplementary Online Content Uranga A, España, Bilbao A, et al. Duration of antibiotic treatment in communityacquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. ublished online
More informationINTELLiVENT -ASV insight. Alexandra Geiger CAS, Dr. Marc Wysocki, Head of Medical Research Hamilton Medical
INTELLiVENT -ASV insight Alexandra Geiger CAS, Dr. Marc Wysocki, Head of Medical Research Hamilton Medical First Automation of HAMILTON MEDICAL 1998 Adaptive Support Ventilation (ASV) ASV optimize VT and
More informationEffect of peak inspiratory pressure on the development. of postoperative pulmonary complications.
Effect of peak inspiratory pressure on the development of postoperative pulmonary complications in mechanically ventilated adult surgical patients: a systematic review protocol Chelsa Wamsley Donald Missel
More informationWhat s New About Proning?
1 What s New About Proning? J. Brady Scott, MSc, RRT-ACCS, AE-C, FAARC Director of Clinical Education and Assistant Professor Department of Cardiopulmonary Sciences Division of Respiratory Care Rush University
More informationRESPIRATORY COMPLICATIONS AFTER SCI
SHEPHERD.ORG RESPIRATORY COMPLICATIONS AFTER SCI NORMA I RIVERA, RRT, RCP RESPIRATORY EDUCATOR SHEPHERD CENTER 2020 Peachtree Road, NW, Atlanta, GA 30309-1465 404-352-2020 DISCLOSURE STATEMENT I have no
More informationProposed presentation of data for ICU-ROX.
Proposed presentation of data for ICU-ROX. Version 1 was posted online on 21 November 2017 (prior to the interim analysis which occurred when the 500 th participant reached day 28). This version (version
More informationAPPENDIX VI HFOV Quick Guide
APPENDIX VI HFOV Quick Guide Overall goal: Maintain PH in the target range at the minimum tidal volume. This is achieved by favoring higher frequencies over lower P (amplitude). This goal is also promoted
More informationYear in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen
Year in Review 2013 Intensive Care Training Program Radboud University Medical Centre Nijmegen Contents ARDS Ventilator associated pneumonia Tracheostomy and endotracheal intubation Enteral feeding Fluid
More informationTHE USE OF HYPERINFLATION IN THE MANAGEMENT OF INTUBATED AND VENTILATED ADULT PATIENTS RECOMMENDATIONS
THE USE OF HYPERINFLATION IN THE MANAGEMENT OF INTUBATED AND VENTILATED ADULT PATIENTS RECOMMENDATIONS Recommendation 1 on website Hyperinflation (Ventilator or manual) might be included in the management
More informationHigh Flow Oxygen Therapy in Acute Respiratory Failure. Laurent Brochard Toronto
High Flow Oxygen Therapy in Acute Respiratory Failure Laurent Brochard Toronto Conflicts of interest Our clinical research laboratory has received research grants for clinical research projects from the
More informationCASE PRESENTATION VV ECMO
CASE PRESENTATION VV ECMO Joshua Huelster, MD Fellow in Critical Care Medicine Department of Pulmonary and Critical Care Medicine Hennepin County Medical Center Disclosure There are no conflicts of interest
More informationProtecting the Lungs
Protecting the Lungs PGA New York 12/07 Disclosures: Peter Slinger MD, FRCPC University of Toronto 58 y.o. Male, Chronic Gallstone Pancreatitis, Open Cholecystectomy 100 pack/year smoker Dyspnea > 1 block
More informationSample Case Study. The patient was a 77-year-old female who arrived to the emergency room on
Sample Case Study The patient was a 77-year-old female who arrived to the emergency room on February 25 th with a chief complaint of shortness of breath and a deteriorating pulmonary status along with
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationPart 2 of park s Ventilator and ARDS slides for syllabus
Part 2 of park s Ventilator and ARDS slides for syllabus Early Neuromuscular Blockade Question 4 The early use of cis-atracurium in severe ARDS is: A. Contraindicated in patients with diabetes B. Associated
More informationSub-category: Intensive Care for Respiratory Distress
Course n : Course 3 Title: RESPIRATORY PHYSIOLOGY, PHYSICS AND PATHOLOGY IN RELATION TO ANAESTHESIA AND INTENSIVE CARE Sub-category: Intensive Care for Respiratory Distress Topic: Acute Respiratory Distress
More informationCase Scenario 3: Shock and Sepsis
Name: Molly Boyle 1. Define the term shock (Lewis textbook): Shock is a syndrome characterized by decreased perfusion and impaired metabolism. Shock can have a number of causes that result in damage to
More informationSpontaneous Breathing Trial and Mechanical Ventilation Weaning Process
Page 1 of 5 ASSESSMENT INTERVENTION Patient receiving mechanical ventilation Baseline ventilatory mode/ settings RT and RN to assess criteria 1 for SBT Does patient meet criteria? RT to initiate SBT Does
More informationThe new ARDS definitions: what does it mean?
The new ARDS definitions: what does it mean? Richard Beale 7 th September 2012 METHODS ESICM convened an international panel of experts, with representation of ATS and SCCM The objectives were to update
More informationMechanical ventilation in the emergency department
Mechanical ventilation in the emergency department Intubation and mechanical ventilation are often needed in emergency treatment. A ENGELBRECHT, MB ChB, MMed (Fam Med), Dip PEC, DA Head, Emergency Medicine
More informationERJ Express. Published on August 9, 2012 as doi: /
ERJ Express. Published on August 9, 2012 as doi: 10.1183/09031936.00076912 Extracorporeal membrane oxygenation in a non intubated patient with acute respiratory distress syndrome (ARDS) Olaf Wiesner, *
More informationLung Recruitment Strategies in Anesthesia
Lung Recruitment Strategies in Anesthesia Intraoperative ventilatory management to prevent Post-operative Pulmonary Complications Kook-Hyun Lee, MD, PhD Department of Anesthesiology Seoul National University
More informationCase Scenarios. Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC. Consultant, Critical Care Medicine Medanta, The Medicity
Case Scenarios Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Case 1 A 36 year male with cirrhosis and active GI bleeding is intubated to protect his airway,
More informationSurviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM
1 Surviving Sepsis Brian Woodcock MBChB MRCP FRCA FCCM 2 Disclosures No conflicts of interest 3 Sepsis Principles of management of septic shock in the operating room "Surviving Sepsis" guidelines 4 Add-on
More informationSuperiority of respiratory failure risk index in prediction of postoperative pulmonary complications after digestive surgery in Japanese patients
Superiority of respiratory failure risk index in prediction of postoperative pulmonary complications after digestive surgery in Japanese patients Satoshi Hokari a, Yasuyoshi Ohshima a, Hideaki Nakayama
More informationA Comparative Study for the Lung Mechanics during One-Lung Ventilation in Thoracic Surgeries Using Two Different Modes of Mechanical Ventilation
Med. J. Cairo Univ., Vol. 85, No. 3, June: 967-972, 2017 www.medicaljournalofcairouniversity.net A Comparative Study for the Lung Mechanics during One-Lung Ventilation in Thoracic Surgeries Using Two Different
More informationPrepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor
Mechanical Ventilation Prepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor 1 Definition Is a supportive therapy to facilitate gas exchange. Most ventilatory support requires an artificial airway.
More informationR2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital
R2R: Severe sepsis/septic shock Surat Tongyoo Critical care medicine Siriraj Hospital Diagnostic criteria ACCP/SCCM consensus conference 1991 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
More informationOptimize vent weaning and SBT outcomes. Identify underlying causes for SBT failures. Role SBT and weaning protocol have in respiratory care
Optimize vent weaning and SBT outcomes Identify underlying causes for SBT failures Role SBT and weaning protocol have in respiratory care Lower risk of developing complications Lower risk of VAP, other
More informationAnesthesia of robotic thoracic surgery
Robotic Thoracic Surgery Column Page 1 of 7 Anesthesia of robotic thoracic surgery Yinan Zhang 1, Shumin Wang 2, Yingjie Sun 1 1 Department of Anesthesiology, 2 Department of Thoracic Surgery, Northern
More informationOutcomes From Severe ARDS Managed Without ECMO. Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016
Outcomes From Severe ARDS Managed Without ECMO Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016 Severe ARDS Berlin Definition 2012 P:F ratio 100 mm Hg Prevalence:
More informationRecognizing and Correcting Patient-Ventilator Dysynchrony
2019 KRCS Annual State Education Seminar Recognizing and Correcting Patient-Ventilator Dysynchrony Eric Kriner BS,RRT Pulmonary Critical Care Clinical Specialist MedStar Washington Hospital Center Washington,
More informationDifficult Ventilation in ARDS Patients
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.
More informationManagement of Acute Exacerbations
15 Management of Acute Exacerbations Cenk Kirakli Izmir Dr. Suat Seren Chest Diseases and Surgery Training Hospital Turkey 1. Introduction American Thoracic Society (ATS) and European Respiratory Society
More informationMechanical Ventilation 1. Shari McKeown, RRT Respiratory Services - VGH
Mechanical Ventilation 1 Shari McKeown, RRT Respiratory Services - VGH Objectives Describe indications for mcvent Describe types of breaths and modes of ventilation Describe compliance and resistance and
More informationNIV in hypoxemic patients
NIV in hypoxemic patients Massimo Antonelli, MD Dept. of Intensive Care & Anesthesiology Università Cattolica del Sacro Cuore Rome - Italy Conflict of interest (research grants and consultations): Maquet
More information7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability
Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Identify the 5 criteria for the diagnosis of ARDS. Discuss the common etiologies
More informationTest Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo
Instant dowload and all chapters Test Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo https://testbanklab.com/download/test-bank-pilbeams-mechanical-ventilation-physiologicalclinical-applications-6th-edition-cairo/
More information3 papers from ED. counting sepsis sepsis 3 wet or dry?
3 papers from ED counting sepsis sepsis 3 wet or dry? 5 million deaths/yr globally 24 billion USD annually in US system causes or contributes to half of US hospital deaths BP GCS RR From: The Third International
More informationSepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand
Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand Vital signs Symptoms LAB BT > 38.3 or < 36 ๐ C HR > 90 bpm RR > 20 /min
More informationPerioperative Pulmonary Management. Objectives
Citywide Resident Perioperative Medical Consult Conference Perioperative Pulmonary Management Frank Jacono, MD May 5, 2017 Objectives Definition of post-operative pulmonary complications (PPC) Risk factors
More informationRounds in the ICU. Eran Segal, MD Director General ICU Sheba Medical Center
Rounds in the ICU Eran Segal, MD Director General ICU Sheba Medical Center Real Clinical cases (including our mistakes) Emphasis on hemodynamic monitoring Usually no single correct answer We will conduct
More informationAdmissions with severe sepsis in adult, general critical care units in England, Wales and Northern Ireland
Admissions with severe sepsis in adult, general critical care units in England, Wales and Northern Ireland Question For all admissions to adult, general critical care units in the Case Mix Programme Database
More informationPost Arrest Ventilation/Oxygenation Management
Post Arrest Ventilation/Oxygenation Management Richard Branson MSc RRT Professor of Surgery University of Cincinnati Editor-In-Chief Respiratory Care 0 Presenter Disclosure Information Richard Branson
More informationC h a p t e r 1 4 Ventilator Support
C h a p t e r 1 4 Ventilator Support Shirish Prayag Ex. Hon. Asst. Prof of Medicine, BJ Medical College and Sassoon Hospital, Pune; Chief Consultant in Internal Medicine and Critical Care, Shree Medical
More information